Cognitive enhancing drugs in aphasia: A vote for hope

Aphasiology

Volumn 28, Issue 2, 2014, Pages 128-132

  Berthier, Marcelo L ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BROMOCRIPTINE; DONEPEZIL; GALANTAMINE; GLUTAMIC ACID; LEVODOPA; MEMANTINE; NEUROTRANSMITTER; PROPRANOLOL;

ANXIETY; APHASIA; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COMMUNICATION DISORDER; DEMENTIA; DEPRESSION; EDITORIAL; HUMAN; LIFESTYLE MODIFICATION; PARKINSON DISEASE; SOCIAL ISOLATION; STRESS; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

EID: 84890408764     PISSN: 02687038     EISSN: 14645041     Source Type: Journal    
DOI: 10.1080/02687038.2013.857756     Document Type: Editorial

References (24)

1. Basso, A., Forbes, M., & Boller, F. (2013). Rehabilitation of aphasia. Handbook of Clinical Neurology, 110, 325-334. doi:10.1016/B978-0-444-52901-5.00027-7
2. Berthier, M. L., Dávila, G., Green, C., Moreno-Torres, I., Juárez y Ruiz de Mier, R., De-Torres, I, & Ruiz-Cruces, R. (2014). Massed sentence repetition training can augment and speed up recovery of speech production deficits in patients with chronic conduction aphasia receiving donepezil treatment. Aphasiology, 28, 188-218.
3. Berthier, M. L., Pulvermüller, F., Dávila, G., Casares, N., & Gutiérrez, A. (2011). Drug therapy of post-stroke aphasia: A review of current evidence. Neuropsychology Review, 21, 302-317. doi:10.1007/s11065-011-9177-7
4. Cahana-Amitay, D., Albert, M. L., & Oveis, A. (2014). Psycholinguistics of aphasia pharmacotherapy: Asking the right questions. Aphasiology, 28, 133-154.
5. Cherney, L. R., Harvey, R. L., Babbitt, E. M., Hurwitz, R., Kaye, R. C., Lee, J. B., Small, S. L. (2012). Epidural cortical stimulation and aphasia therapy. Aphasiology, 26, 1192-1217. doi:10.1080/02687038.2011.603719
6. Cicerone, K. D., Langenbahn, D. M., Braden, C., Malec, J. F., Kalmar, K., Fraas, M., Ashman, T. (2011). Evidence-based cognitive rehabilitation: Updated review of the literature from 2003 through 2008. Archives of Physical Medicine and Rehabilitation, 92, 519-530. doi:10.1016/j.apmr.2010.11.015
7. Code, C., & Petheram, B. (2011). Delivering for aphasia. International Journal of Speech and Language Pathology, 13, 3-10. doi:10.3109/17549507.2010.520090
8. Crinion, J. (2012). Shocking speech. Aphasiology, 26, 1077-1081. doi:10.1080/02687038.2012.714215
9. Falchook, A. D., Heilman, K. M., Finney, G. R., Gonzalez-Rothi, L. J., & Nadeau, S. E. (2014). Neuroplasticity, neurotransmitters, and new directions for treatment of anomia in Alzheimer disease. Aphasiology, 28, 219-235.
10. Floel, A., & Cohen, L. G. (2010). Recovery of function in humans: Cortical stimulation and pharmacological treatments after stroke. Neurobiology of Disease, 37, 243-251. doi:10.1016/j.nbd.2009.05.027
11. Fucetola, R., Tucker, F., Blank, K., & Corbetta, M. (2005). A process for translating evidence-based aphasia treatment into clinical practice. Aphasiology, 19, 411-422. doi:10.1080/02687030444000859
12. Galling, M. A., Goorah, N., Berthier, M. L., & Sage, K. (2014). A clinical study of the combined use of bromocriptine and speech and language therapy in the treatment of a person with aphasia. Aphasiology, 28, 171-187.
13. Gill, S. K., & Leff, A. (2014). Dopaminergic therapy in aphasia. Aphasiology, 28, 155-170.
14. Holland, R., & Crinion, J. (2012). Can tDCS enhance treatment of aphasia after stroke? Aphasiology, 26, 1169-1191. doi:10.1080/02687038.2011.616925
15. Husain, M., & Mehta, M. A. (2011). Cognitive enhancement by drugs in health and disease. Trends in Cognitive Sciences, 15, 28-36. doi:10.1016/j.tics.2010.11.002
16. Pulvermüller, F., & Berthier, M. L. (2008). Aphasia therapy on a neuroscience basis. Aphasiology, 22, 563-599. doi:10.1080/02687030701612213
17. Repantis, D., Laisney, O., & Heuser, I. (2010). Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research, 61, 473-481. doi:10.1016/j.phrs.2010.02.009
18. Salter, K., Teasell, R., Bhogal, S., Zettler, L., & Foley, N. (2012). The evidence-based review of stroke rehabilitation (EBRSR) reviews current practices in stroke rehabilitation. (Chapter 14: Aphasia). Retrieved from http:\\www.ebrsr.com.
19. Saxton, J., Hofbauer, R. K., Woodward, M., Gilchrist, N. L., Potocnik, F., & Hsu, H. A. (2012). Memantine and functional communication in Alzheimer's disease: Results of a 12-week, international, randomized clinical trial. Journal of Alzheimer's Disease, 28, 109-118.
20. Shisler, R. J., Baylis, G. C., & Frank, E. M. (2000). Pharmacological approaches to the treatment and prevention of aphasia. Aphasiology, 14, 1163-1186. doi:10.1080/02687030050205705
21. Small, S. L., & Llano, D. A. (2009). Biological approaches to aphasia treatment. Current Neurology and Neuroscience Reports, 9, 443-450. doi:10.1007/s11910-009-0066-x
22. Teasell, R., Foley, N., Salter, K., Bhogal, S., Jutai, J., & Speechley, M. (2012). Evidence-based review of stroke rehabilitation. Executive summary (15th ed.). Retrieved from http:\\www.ebrsr.com
23. Tocco, M., Bayles, K., Lopez, O. L., Hofbauer, R. K., Pejović, V., Miller, M. L., Saxton, J. (2014). Effects of memantine treatment on language abilities and functional communication: A review of data. Aphasiology, 28, 236-257.
24. Varley, R. (2011). Rethinking aphasia therapy: A neuroscience perspective. International Journal of Speech-Language Pathology, 13, 11-20. doi:10.3109/17549507.2010.497561